nodes	percent_of_prediction	percent_of_DWPC	metapath
Azathioprine—Nucleic Acid Synthesis Inhibitors—Capecitabine—colon cancer	0.299	0.515	CiPCiCtD
Azathioprine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—colon cancer	0.281	0.485	CiPCiCtD
Azathioprine—Crohn's disease—colon cancer	0.215	0.585	CtDrD
Azathioprine—ulcerative colitis—colon cancer	0.152	0.415	CtDrD
Azathioprine—GSTA1—gall bladder—colon cancer	0.00191	0.0742	CbGeAlD
Azathioprine—GSTM1—blood vessel—colon cancer	0.0015	0.0583	CbGeAlD
Azathioprine—GSTA2—gall bladder—colon cancer	0.00138	0.0535	CbGeAlD
Azathioprine—GSTA1—embryo—colon cancer	0.00121	0.047	CbGeAlD
Azathioprine—GSTA1—epithelium—colon cancer	0.000986	0.0384	CbGeAlD
Azathioprine—Lymphoproliferative disorder—Methotrexate—colon cancer	0.000979	0.0387	CcSEcCtD
Azathioprine—X-linked lymphoproliferative syndrome—Methotrexate—colon cancer	0.000979	0.0387	CcSEcCtD
Azathioprine—Acute leukaemia—Irinotecan—colon cancer	0.000931	0.0368	CcSEcCtD
Azathioprine—HPRT1—embryo—colon cancer	0.000916	0.0356	CbGeAlD
Azathioprine—GSTA1—renal system—colon cancer	0.000914	0.0356	CbGeAlD
Azathioprine—GSTA2—embryo—colon cancer	0.000872	0.0339	CbGeAlD
Azathioprine—Hepatic insufficiency—Methotrexate—colon cancer	0.000857	0.0339	CcSEcCtD
Azathioprine—GSTA1—lymphoid tissue—colon cancer	0.000759	0.0295	CbGeAlD
Azathioprine—GSTA1—digestive system—colon cancer	0.00075	0.0292	CbGeAlD
Azathioprine—HPRT1—smooth muscle tissue—colon cancer	0.00072	0.028	CbGeAlD
Azathioprine—GSTA2—epithelium—colon cancer	0.000711	0.0277	CbGeAlD
Azathioprine—HPRT1—renal system—colon cancer	0.000693	0.027	CbGeAlD
Azathioprine—XDH—renal system—colon cancer	0.000684	0.0266	CbGeAlD
Azathioprine—GSTM1—renal system—colon cancer	0.000676	0.0263	CbGeAlD
Azathioprine—Intestinal perforation—Irinotecan—colon cancer	0.000673	0.0266	CcSEcCtD
Azathioprine—GSTA2—renal system—colon cancer	0.00066	0.0257	CbGeAlD
Azathioprine—TPMT—renal system—colon cancer	0.000584	0.0227	CbGeAlD
Azathioprine—Myelosuppression—Vincristine—colon cancer	0.000583	0.023	CcSEcCtD
Azathioprine—HPRT1—lymphoid tissue—colon cancer	0.000575	0.0224	CbGeAlD
Azathioprine—HPRT1—digestive system—colon cancer	0.000568	0.0221	CbGeAlD
Azathioprine—Anaemia megaloblastic—Methotrexate—colon cancer	0.000563	0.0222	CcSEcCtD
Azathioprine—GSTM1—lymphoid tissue—colon cancer	0.000562	0.0219	CbGeAlD
Azathioprine—XDH—digestive system—colon cancer	0.000561	0.0218	CbGeAlD
Azathioprine—GSTA1—liver—colon cancer	0.000559	0.0217	CbGeAlD
Azathioprine—GSTM1—digestive system—colon cancer	0.000555	0.0216	CbGeAlD
Azathioprine—GSTA2—lymphoid tissue—colon cancer	0.000548	0.0213	CbGeAlD
Azathioprine—Myelosuppression—Fluorouracil—colon cancer	0.000543	0.0215	CcSEcCtD
Azathioprine—GSTA2—digestive system—colon cancer	0.000541	0.0211	CbGeAlD
Azathioprine—HPRT1—bone marrow—colon cancer	0.000524	0.0204	CbGeAlD
Azathioprine—HPRT1—vagina—colon cancer	0.000502	0.0195	CbGeAlD
Azathioprine—XDH—vagina—colon cancer	0.000496	0.0193	CbGeAlD
Azathioprine—TPMT—bone marrow—colon cancer	0.000442	0.0172	CbGeAlD
Azathioprine—HPRT1—liver—colon cancer	0.000423	0.0165	CbGeAlD
Azathioprine—TPMT—vagina—colon cancer	0.000423	0.0165	CbGeAlD
Azathioprine—XDH—liver—colon cancer	0.000418	0.0163	CbGeAlD
Azathioprine—GSTM1—liver—colon cancer	0.000413	0.0161	CbGeAlD
Azathioprine—Bone marrow depression—Vincristine—colon cancer	0.000405	0.016	CcSEcCtD
Azathioprine—GSTA2—liver—colon cancer	0.000403	0.0157	CbGeAlD
Azathioprine—Reaction gastrointestinal—Methotrexate—colon cancer	0.000397	0.0157	CcSEcCtD
Azathioprine—Lymphoma—Methotrexate—colon cancer	0.000379	0.015	CcSEcCtD
Azathioprine—TPMT—Metapathway biotransformation—CHST4—colon cancer	0.000372	0.131	CbGpPWpGaD
Azathioprine—TPMT—liver—colon cancer	0.000357	0.0139	CbGeAlD
Azathioprine—Intestinal perforation—Methotrexate—colon cancer	0.000335	0.0133	CcSEcCtD
Azathioprine—HPRT1—lymph node—colon cancer	0.000325	0.0126	CbGeAlD
Azathioprine—GSTM1—lymph node—colon cancer	0.000317	0.0123	CbGeAlD
Azathioprine—Neoplasm malignant—Irinotecan—colon cancer	0.000312	0.0123	CcSEcCtD
Azathioprine—GSTM1—Metapathway biotransformation—CHST4—colon cancer	0.000303	0.107	CbGpPWpGaD
Azathioprine—Bacterial infection—Methotrexate—colon cancer	0.000287	0.0114	CcSEcCtD
Azathioprine—Interstitial pneumonia—Methotrexate—colon cancer	0.000274	0.0108	CcSEcCtD
Azathioprine—TPMT—lymph node—colon cancer	0.000274	0.0107	CbGeAlD
Azathioprine—Bone marrow depression—Capecitabine—colon cancer	0.000264	0.0104	CcSEcCtD
Azathioprine—Colitis—Irinotecan—colon cancer	0.000255	0.0101	CcSEcCtD
Azathioprine—Neoplasm—Irinotecan—colon cancer	0.000241	0.00951	CcSEcCtD
Azathioprine—Herpes zoster—Capecitabine—colon cancer	0.000236	0.00935	CcSEcCtD
Azathioprine—Hepatotoxicity—Capecitabine—colon cancer	0.000231	0.00912	CcSEcCtD
Azathioprine—Hepatic failure—Vincristine—colon cancer	0.000221	0.00873	CcSEcCtD
Azathioprine—Rigors—Capecitabine—colon cancer	0.000218	0.00863	CcSEcCtD
Azathioprine—Polyp—Methotrexate—colon cancer	0.000218	0.00862	CcSEcCtD
Azathioprine—Cyst—Methotrexate—colon cancer	0.000198	0.00784	CcSEcCtD
Azathioprine—Bone marrow depression—Methotrexate—colon cancer	0.000196	0.00777	CcSEcCtD
Azathioprine—Interstitial lung disease—Methotrexate—colon cancer	0.000187	0.00741	CcSEcCtD
Azathioprine—Herpes zoster—Methotrexate—colon cancer	0.000176	0.00696	CcSEcCtD
Azathioprine—Hepatotoxicity—Methotrexate—colon cancer	0.000172	0.00679	CcSEcCtD
Azathioprine—Colitis—Capecitabine—colon cancer	0.000171	0.00676	CcSEcCtD
Azathioprine—TPMT—Metapathway biotransformation—CHST5—colon cancer	0.000171	0.0602	CbGpPWpGaD
Azathioprine—Pancreatitis—Irinotecan—colon cancer	0.000164	0.00647	CcSEcCtD
Azathioprine—Pancytopenia—Vincristine—colon cancer	0.000163	0.00644	CcSEcCtD
Azathioprine—Neoplasm—Capecitabine—colon cancer	0.000161	0.00637	CcSEcCtD
Azathioprine—Pneumonia—Vincristine—colon cancer	0.000154	0.00608	CcSEcCtD
Azathioprine—Pancytopenia—Fluorouracil—colon cancer	0.000152	0.006	CcSEcCtD
Azathioprine—Pneumonia—Irinotecan—colon cancer	0.00015	0.00592	CcSEcCtD
Azathioprine—Hepatic function abnormal—Capecitabine—colon cancer	0.000148	0.00585	CcSEcCtD
Azathioprine—GSTA2—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000147	0.0519	CbGpPWpGaD
Azathioprine—Hepatic failure—Capecitabine—colon cancer	0.000144	0.00569	CcSEcCtD
Azathioprine—Pneumonia—Fluorouracil—colon cancer	0.000143	0.00567	CcSEcCtD
Azathioprine—Infestation NOS—Fluorouracil—colon cancer	0.000143	0.00564	CcSEcCtD
Azathioprine—Infestation—Fluorouracil—colon cancer	0.000143	0.00564	CcSEcCtD
Azathioprine—GSTM1—Metapathway biotransformation—CHST5—colon cancer	0.000139	0.0491	CbGpPWpGaD
Azathioprine—Vasculitis—Methotrexate—colon cancer	0.000136	0.00537	CcSEcCtD
Azathioprine—Haemoglobin—Irinotecan—colon cancer	0.000134	0.00531	CcSEcCtD
Azathioprine—Haemorrhage—Irinotecan—colon cancer	0.000134	0.00528	CcSEcCtD
Azathioprine—Agranulocytosis—Fluorouracil—colon cancer	0.000133	0.00526	CcSEcCtD
Azathioprine—Haemoglobin—Fluorouracil—colon cancer	0.000129	0.00509	CcSEcCtD
Azathioprine—Haemorrhage—Fluorouracil—colon cancer	0.000128	0.00506	CcSEcCtD
Azathioprine—Aplastic anaemia—Methotrexate—colon cancer	0.000124	0.00492	CcSEcCtD
Azathioprine—Mediastinal disorder—Vincristine—colon cancer	0.000124	0.00489	CcSEcCtD
Azathioprine—Alopecia—Vincristine—colon cancer	0.000121	0.00479	CcSEcCtD
Azathioprine—Immune system disorder—Irinotecan—colon cancer	0.000121	0.00477	CcSEcCtD
Azathioprine—Mediastinal disorder—Irinotecan—colon cancer	0.00012	0.00476	CcSEcCtD
Azathioprine—HPRT1—Nucleotide metabolism—TYMS—colon cancer	0.00012	0.0423	CbGpPWpGaD
Azathioprine—Chills—Irinotecan—colon cancer	0.00012	0.00474	CcSEcCtD
Azathioprine—Neoplasm—Methotrexate—colon cancer	0.00012	0.00474	CcSEcCtD
Azathioprine—Arrhythmia—Irinotecan—colon cancer	0.000119	0.00472	CcSEcCtD
Azathioprine—Alopecia—Irinotecan—colon cancer	0.000118	0.00467	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000116	0.0046	CcSEcCtD
Azathioprine—Arrhythmia—Fluorouracil—colon cancer	0.000114	0.00452	CcSEcCtD
Azathioprine—Alopecia—Fluorouracil—colon cancer	0.000113	0.00447	CcSEcCtD
Azathioprine—Anaemia—Vincristine—colon cancer	0.00011	0.00437	CcSEcCtD
Azathioprine—Ill-defined disorder—Irinotecan—colon cancer	0.000108	0.00427	CcSEcCtD
Azathioprine—Anaemia—Irinotecan—colon cancer	0.000107	0.00425	CcSEcCtD
Azathioprine—Abdominal discomfort—Capecitabine—colon cancer	0.000107	0.00424	CcSEcCtD
Azathioprine—Hepatic failure—Methotrexate—colon cancer	0.000107	0.00423	CcSEcCtD
Azathioprine—Leukopenia—Vincristine—colon cancer	0.000107	0.00423	CcSEcCtD
Azathioprine—Pancytopenia—Capecitabine—colon cancer	0.000106	0.0042	CcSEcCtD
Azathioprine—Malaise—Irinotecan—colon cancer	0.000105	0.00415	CcSEcCtD
Azathioprine—GSTA2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	0.000104	0.0367	CbGpPWpGaD
Azathioprine—Leukopenia—Irinotecan—colon cancer	0.000104	0.00412	CcSEcCtD
Azathioprine—Anaemia—Fluorouracil—colon cancer	0.000103	0.00407	CcSEcCtD
Azathioprine—Myalgia—Vincristine—colon cancer	0.000102	0.00402	CcSEcCtD
Azathioprine—Pneumonia—Capecitabine—colon cancer	0.0001	0.00396	CcSEcCtD
Azathioprine—Leukopenia—Fluorouracil—colon cancer	9.97e-05	0.00394	CcSEcCtD
Azathioprine—Infestation NOS—Capecitabine—colon cancer	9.96e-05	0.00394	CcSEcCtD
Azathioprine—Infestation—Capecitabine—colon cancer	9.96e-05	0.00394	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Capecitabine—colon cancer	9.88e-05	0.00391	CcSEcCtD
Azathioprine—Discomfort—Irinotecan—colon cancer	9.78e-05	0.00387	CcSEcCtD
Azathioprine—Infection—Vincristine—colon cancer	9.68e-05	0.00383	CcSEcCtD
Azathioprine—Thrombocytopenia—Vincristine—colon cancer	9.54e-05	0.00377	CcSEcCtD
Azathioprine—Myalgia—Fluorouracil—colon cancer	9.48e-05	0.00375	CcSEcCtD
Azathioprine—Infection—Irinotecan—colon cancer	9.43e-05	0.00373	CcSEcCtD
Azathioprine—Hepatobiliary disease—Capecitabine—colon cancer	9.42e-05	0.00373	CcSEcCtD
Azathioprine—Discomfort—Fluorouracil—colon cancer	9.37e-05	0.00371	CcSEcCtD
Azathioprine—Agranulocytosis—Capecitabine—colon cancer	9.3e-05	0.00368	CcSEcCtD
Azathioprine—Thrombocytopenia—Irinotecan—colon cancer	9.29e-05	0.00368	CcSEcCtD
Azathioprine—Hypotension—Vincristine—colon cancer	9.11e-05	0.0036	CcSEcCtD
Azathioprine—GSTA2—Transcriptional activation by NRF2—PIK3CA—colon cancer	9.08e-05	0.032	CbGpPWpGaD
Azathioprine—Infection—Fluorouracil—colon cancer	9.03e-05	0.00357	CcSEcCtD
Azathioprine—Haemoglobin—Capecitabine—colon cancer	8.99e-05	0.00355	CcSEcCtD
Azathioprine—Haemorrhage—Capecitabine—colon cancer	8.94e-05	0.00354	CcSEcCtD
Azathioprine—Thrombocytopenia—Fluorouracil—colon cancer	8.9e-05	0.00352	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Vincristine—colon cancer	8.88e-05	0.00351	CcSEcCtD
Azathioprine—Hypotension—Irinotecan—colon cancer	8.87e-05	0.00351	CcSEcCtD
Azathioprine—Toxic epidermal necrolysis—Methotrexate—colon cancer	8.66e-05	0.00343	CcSEcCtD
Azathioprine—Hypotension—Fluorouracil—colon cancer	8.49e-05	0.00336	CcSEcCtD
Azathioprine—Erythema multiforme—Capecitabine—colon cancer	8.45e-05	0.00334	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Vincristine—colon cancer	8.41e-05	0.00333	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Fluorouracil—colon cancer	8.28e-05	0.00328	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Irinotecan—colon cancer	8.19e-05	0.00324	CcSEcCtD
Azathioprine—Pancreatitis—Methotrexate—colon cancer	8.15e-05	0.00322	CcSEcCtD
Azathioprine—Immune system disorder—Capecitabine—colon cancer	8.08e-05	0.00319	CcSEcCtD
Azathioprine—Mediastinal disorder—Capecitabine—colon cancer	8.06e-05	0.00319	CcSEcCtD
Azathioprine—Chills—Capecitabine—colon cancer	8.02e-05	0.00317	CcSEcCtD
Azathioprine—Arrhythmia—Capecitabine—colon cancer	7.99e-05	0.00316	CcSEcCtD
Azathioprine—Abdominal discomfort—Methotrexate—colon cancer	7.97e-05	0.00315	CcSEcCtD
Azathioprine—Gastrointestinal pain—Vincristine—colon cancer	7.97e-05	0.00315	CcSEcCtD
Azathioprine—Alopecia—Capecitabine—colon cancer	7.9e-05	0.00313	CcSEcCtD
Azathioprine—Pancytopenia—Methotrexate—colon cancer	7.9e-05	0.00312	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Fluorouracil—colon cancer	7.85e-05	0.0031	CcSEcCtD
Azathioprine—Feeling abnormal—Irinotecan—colon cancer	7.82e-05	0.00309	CcSEcCtD
Azathioprine—Gastrointestinal pain—Irinotecan—colon cancer	7.76e-05	0.00307	CcSEcCtD
Azathioprine—Body temperature increased—Vincristine—colon cancer	7.7e-05	0.00305	CcSEcCtD
Azathioprine—Abdominal pain—Vincristine—colon cancer	7.7e-05	0.00305	CcSEcCtD
Azathioprine—Abdominal pain—Irinotecan—colon cancer	7.5e-05	0.00297	CcSEcCtD
Azathioprine—Body temperature increased—Irinotecan—colon cancer	7.5e-05	0.00297	CcSEcCtD
Azathioprine—Feeling abnormal—Fluorouracil—colon cancer	7.49e-05	0.00296	CcSEcCtD
Azathioprine—Pneumonia—Methotrexate—colon cancer	7.46e-05	0.00295	CcSEcCtD
Azathioprine—Infestation—Methotrexate—colon cancer	7.42e-05	0.00293	CcSEcCtD
Azathioprine—Infestation NOS—Methotrexate—colon cancer	7.42e-05	0.00293	CcSEcCtD
Azathioprine—Stevens-Johnson syndrome—Methotrexate—colon cancer	7.35e-05	0.00291	CcSEcCtD
Azathioprine—Ill-defined disorder—Capecitabine—colon cancer	7.22e-05	0.00286	CcSEcCtD
Azathioprine—Anaemia—Capecitabine—colon cancer	7.19e-05	0.00285	CcSEcCtD
Azathioprine—Body temperature increased—Fluorouracil—colon cancer	7.19e-05	0.00284	CcSEcCtD
Azathioprine—Hypersensitivity—Vincristine—colon cancer	7.18e-05	0.00284	CcSEcCtD
Azathioprine—Malaise—Capecitabine—colon cancer	7.02e-05	0.00278	CcSEcCtD
Azathioprine—Hepatobiliary disease—Methotrexate—colon cancer	7.01e-05	0.00277	CcSEcCtD
Azathioprine—Hypersensitivity—Irinotecan—colon cancer	6.99e-05	0.00277	CcSEcCtD
Azathioprine—Leukopenia—Capecitabine—colon cancer	6.97e-05	0.00276	CcSEcCtD
Azathioprine—HPRT1—Metabolism—CA7—colon cancer	6.93e-05	0.0244	CbGpPWpGaD
Azathioprine—Agranulocytosis—Methotrexate—colon cancer	6.92e-05	0.00274	CcSEcCtD
Azathioprine—Hypersensitivity—Fluorouracil—colon cancer	6.7e-05	0.00265	CcSEcCtD
Azathioprine—Haemoglobin—Methotrexate—colon cancer	6.69e-05	0.00265	CcSEcCtD
Azathioprine—Diarrhoea—Vincristine—colon cancer	6.67e-05	0.00264	CcSEcCtD
Azathioprine—Haemorrhage—Methotrexate—colon cancer	6.66e-05	0.00263	CcSEcCtD
Azathioprine—Myalgia—Capecitabine—colon cancer	6.63e-05	0.00262	CcSEcCtD
Azathioprine—Arthralgia—Capecitabine—colon cancer	6.63e-05	0.00262	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	6.58e-05	0.0026	CcSEcCtD
Azathioprine—Discomfort—Capecitabine—colon cancer	6.55e-05	0.00259	CcSEcCtD
Azathioprine—Diarrhoea—Irinotecan—colon cancer	6.49e-05	0.00257	CcSEcCtD
Azathioprine—Dizziness—Vincristine—colon cancer	6.45e-05	0.00255	CcSEcCtD
Azathioprine—Infection—Capecitabine—colon cancer	6.31e-05	0.0025	CcSEcCtD
Azathioprine—Erythema multiforme—Methotrexate—colon cancer	6.29e-05	0.00249	CcSEcCtD
Azathioprine—Dizziness—Irinotecan—colon cancer	6.28e-05	0.00248	CcSEcCtD
Azathioprine—Diarrhoea—Fluorouracil—colon cancer	6.22e-05	0.00246	CcSEcCtD
Azathioprine—Thrombocytopenia—Capecitabine—colon cancer	6.22e-05	0.00246	CcSEcCtD
Azathioprine—Vomiting—Vincristine—colon cancer	6.2e-05	0.00245	CcSEcCtD
Azathioprine—Skin disorder—Capecitabine—colon cancer	6.17e-05	0.00244	CcSEcCtD
Azathioprine—Rash—Vincristine—colon cancer	6.15e-05	0.00243	CcSEcCtD
Azathioprine—Dermatitis—Vincristine—colon cancer	6.14e-05	0.00243	CcSEcCtD
Azathioprine—Headache—Vincristine—colon cancer	6.11e-05	0.00241	CcSEcCtD
Azathioprine—GSTA1—Metabolism—CA7—colon cancer	6.06e-05	0.0214	CbGpPWpGaD
Azathioprine—Vomiting—Irinotecan—colon cancer	6.04e-05	0.00239	CcSEcCtD
Azathioprine—Immune system disorder—Methotrexate—colon cancer	6.01e-05	0.00238	CcSEcCtD
Azathioprine—Dizziness—Fluorouracil—colon cancer	6.01e-05	0.00238	CcSEcCtD
Azathioprine—Mediastinal disorder—Methotrexate—colon cancer	6e-05	0.00237	CcSEcCtD
Azathioprine—Rash—Irinotecan—colon cancer	5.98e-05	0.00237	CcSEcCtD
Azathioprine—Dermatitis—Irinotecan—colon cancer	5.98e-05	0.00236	CcSEcCtD
Azathioprine—Chills—Methotrexate—colon cancer	5.97e-05	0.00236	CcSEcCtD
Azathioprine—Headache—Irinotecan—colon cancer	5.95e-05	0.00235	CcSEcCtD
Azathioprine—Hypotension—Capecitabine—colon cancer	5.94e-05	0.00235	CcSEcCtD
Azathioprine—Alopecia—Methotrexate—colon cancer	5.88e-05	0.00233	CcSEcCtD
Azathioprine—Nausea—Vincristine—colon cancer	5.79e-05	0.00229	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Capecitabine—colon cancer	5.79e-05	0.00229	CcSEcCtD
Azathioprine—Vomiting—Fluorouracil—colon cancer	5.78e-05	0.00229	CcSEcCtD
Azathioprine—Rash—Fluorouracil—colon cancer	5.73e-05	0.00227	CcSEcCtD
Azathioprine—Dermatitis—Fluorouracil—colon cancer	5.73e-05	0.00227	CcSEcCtD
Azathioprine—Headache—Fluorouracil—colon cancer	5.7e-05	0.00225	CcSEcCtD
Azathioprine—Nausea—Irinotecan—colon cancer	5.64e-05	0.00223	CcSEcCtD
Azathioprine—Gastrointestinal disorder—Capecitabine—colon cancer	5.48e-05	0.00217	CcSEcCtD
Azathioprine—Nausea—Fluorouracil—colon cancer	5.4e-05	0.00214	CcSEcCtD
Azathioprine—Ill-defined disorder—Methotrexate—colon cancer	5.38e-05	0.00213	CcSEcCtD
Azathioprine—Anaemia—Methotrexate—colon cancer	5.36e-05	0.00212	CcSEcCtD
Azathioprine—Feeling abnormal—Capecitabine—colon cancer	5.24e-05	0.00207	CcSEcCtD
Azathioprine—Malaise—Methotrexate—colon cancer	5.23e-05	0.00207	CcSEcCtD
Azathioprine—Gastrointestinal pain—Capecitabine—colon cancer	5.19e-05	0.00205	CcSEcCtD
Azathioprine—Leukopenia—Methotrexate—colon cancer	5.19e-05	0.00205	CcSEcCtD
Azathioprine—XDH—Nucleotide metabolism—TYMS—colon cancer	5.12e-05	0.0181	CbGpPWpGaD
Azathioprine—Body temperature increased—Capecitabine—colon cancer	5.02e-05	0.00199	CcSEcCtD
Azathioprine—Abdominal pain—Capecitabine—colon cancer	5.02e-05	0.00199	CcSEcCtD
Azathioprine—GSTA2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	5.01e-05	0.0177	CbGpPWpGaD
Azathioprine—Arthralgia—Methotrexate—colon cancer	4.93e-05	0.00195	CcSEcCtD
Azathioprine—Myalgia—Methotrexate—colon cancer	4.93e-05	0.00195	CcSEcCtD
Azathioprine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	4.9e-05	0.00194	CcSEcCtD
Azathioprine—TPMT—Metabolism—CA7—colon cancer	4.88e-05	0.0172	CbGpPWpGaD
Azathioprine—Discomfort—Methotrexate—colon cancer	4.87e-05	0.00193	CcSEcCtD
Azathioprine—GSTA2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	4.87e-05	0.0172	CbGpPWpGaD
Azathioprine—Infection—Methotrexate—colon cancer	4.7e-05	0.00186	CcSEcCtD
Azathioprine—Hypersensitivity—Capecitabine—colon cancer	4.68e-05	0.00185	CcSEcCtD
Azathioprine—Thrombocytopenia—Methotrexate—colon cancer	4.63e-05	0.00183	CcSEcCtD
Azathioprine—Skin disorder—Methotrexate—colon cancer	4.59e-05	0.00182	CcSEcCtD
Azathioprine—Hypotension—Methotrexate—colon cancer	4.42e-05	0.00175	CcSEcCtD
Azathioprine—GSTA2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	4.35e-05	0.0154	CbGpPWpGaD
Azathioprine—Diarrhoea—Capecitabine—colon cancer	4.35e-05	0.00172	CcSEcCtD
Azathioprine—Musculoskeletal discomfort—Methotrexate—colon cancer	4.31e-05	0.0017	CcSEcCtD
Azathioprine—GSTA2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	4.27e-05	0.0151	CbGpPWpGaD
Azathioprine—Dizziness—Capecitabine—colon cancer	4.2e-05	0.00166	CcSEcCtD
Azathioprine—HPRT1—Metabolism—CHST5—colon cancer	4.2e-05	0.0148	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—ODC1—colon cancer	4.2e-05	0.0148	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—CA7—colon cancer	4.09e-05	0.0144	CbGpPWpGaD
Azathioprine—Gastrointestinal disorder—Methotrexate—colon cancer	4.08e-05	0.00161	CcSEcCtD
Azathioprine—Vomiting—Capecitabine—colon cancer	4.04e-05	0.0016	CcSEcCtD
Azathioprine—Rash—Capecitabine—colon cancer	4.01e-05	0.00158	CcSEcCtD
Azathioprine—Dermatitis—Capecitabine—colon cancer	4e-05	0.00158	CcSEcCtD
Azathioprine—GSTM1—Metabolism—CA7—colon cancer	3.98e-05	0.014	CbGpPWpGaD
Azathioprine—Headache—Capecitabine—colon cancer	3.98e-05	0.00157	CcSEcCtD
Azathioprine—Feeling abnormal—Methotrexate—colon cancer	3.9e-05	0.00154	CcSEcCtD
Azathioprine—Gastrointestinal pain—Methotrexate—colon cancer	3.87e-05	0.00153	CcSEcCtD
Azathioprine—Nausea—Capecitabine—colon cancer	3.77e-05	0.00149	CcSEcCtD
Azathioprine—Body temperature increased—Methotrexate—colon cancer	3.74e-05	0.00148	CcSEcCtD
Azathioprine—Abdominal pain—Methotrexate—colon cancer	3.74e-05	0.00148	CcSEcCtD
Azathioprine—GSTA1—Metabolism—ODC1—colon cancer	3.67e-05	0.0129	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—CHST5—colon cancer	3.67e-05	0.0129	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—PTGS2—colon cancer	3.62e-05	0.0128	CbGpPWpGaD
Azathioprine—Hypersensitivity—Methotrexate—colon cancer	3.48e-05	0.00138	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—CCND1—colon cancer	3.27e-05	0.0115	CbGpPWpGaD
Azathioprine—Diarrhoea—Methotrexate—colon cancer	3.24e-05	0.00128	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—CDKN1A—colon cancer	3.16e-05	0.0112	CbGpPWpGaD
Azathioprine—Dizziness—Methotrexate—colon cancer	3.13e-05	0.00124	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—EP300—colon cancer	3.01e-05	0.0106	CbGpPWpGaD
Azathioprine—Vomiting—Methotrexate—colon cancer	3.01e-05	0.00119	CcSEcCtD
Azathioprine—Rash—Methotrexate—colon cancer	2.98e-05	0.00118	CcSEcCtD
Azathioprine—Dermatitis—Methotrexate—colon cancer	2.98e-05	0.00118	CcSEcCtD
Azathioprine—Headache—Methotrexate—colon cancer	2.96e-05	0.00117	CcSEcCtD
Azathioprine—XDH—Metabolism—CA7—colon cancer	2.96e-05	0.0104	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—CHST5—colon cancer	2.96e-05	0.0104	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—ODC1—colon cancer	2.96e-05	0.0104	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—NRAS—colon cancer	2.82e-05	0.00993	CbGpPWpGaD
Azathioprine—Nausea—Methotrexate—colon cancer	2.81e-05	0.00111	CcSEcCtD
Azathioprine—GSTM1—C-MYB transcription factor network—MYC—colon cancer	2.62e-05	0.00925	CbGpPWpGaD
Azathioprine—XDH—Selenium Micronutrient Network—PTGS2—colon cancer	2.59e-05	0.00914	CbGpPWpGaD
Azathioprine—GSTA1—NRF2 pathway—TGFB1—colon cancer	2.56e-05	0.00902	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—CHST5—colon cancer	2.48e-05	0.00874	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—ODC1—colon cancer	2.48e-05	0.00874	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—KRAS—colon cancer	2.42e-05	0.00855	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—ODC1—colon cancer	2.41e-05	0.00851	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—CHST5—colon cancer	2.41e-05	0.00851	CbGpPWpGaD
Azathioprine—GSTM1—C-MYB transcription factor network—HRAS—colon cancer	2.06e-05	0.00726	CbGpPWpGaD
Azathioprine—XDH—Metabolism—CHST5—colon cancer	1.79e-05	0.00632	CbGpPWpGaD
Azathioprine—XDH—Metabolism—ODC1—colon cancer	1.79e-05	0.00632	CbGpPWpGaD
Azathioprine—GSTA2—NRF2 pathway—TGFB1—colon cancer	1.73e-05	0.0061	CbGpPWpGaD
Azathioprine—GSTM1—NRF2 pathway—TGFB1—colon cancer	1.68e-05	0.00593	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—ABCB1—colon cancer	1.11e-05	0.00391	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—TYMS—colon cancer	1.09e-05	0.00384	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—ABCB1—colon cancer	9.7e-06	0.00342	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—TYMS—colon cancer	9.53e-06	0.00336	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—ABCB1—colon cancer	7.82e-06	0.00276	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PPARG—colon cancer	7.72e-06	0.00272	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—TYMS—colon cancer	7.68e-06	0.00271	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PPARG—colon cancer	6.75e-06	0.00238	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—ABCB1—colon cancer	6.55e-06	0.00231	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—TYMS—colon cancer	6.44e-06	0.00227	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—ABCB1—colon cancer	6.37e-06	0.00225	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—TYMS—colon cancer	6.26e-06	0.00221	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PTGS2—colon cancer	6.07e-06	0.00214	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PPARG—colon cancer	5.44e-06	0.00192	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PTGS2—colon cancer	5.31e-06	0.00187	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—EP300—colon cancer	5.05e-06	0.00178	CbGpPWpGaD
Azathioprine—XDH—Metabolism—ABCB1—colon cancer	4.74e-06	0.00167	CbGpPWpGaD
Azathioprine—XDH—Metabolism—TYMS—colon cancer	4.65e-06	0.00164	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PPARG—colon cancer	4.56e-06	0.00161	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PPARG—colon cancer	4.43e-06	0.00156	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—EP300—colon cancer	4.42e-06	0.00156	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PTGS2—colon cancer	4.28e-06	0.00151	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—PIK3CA—colon cancer	3.74e-06	0.00132	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PTGS2—colon cancer	3.59e-06	0.00126	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—EP300—colon cancer	3.56e-06	0.00126	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PTGS2—colon cancer	3.49e-06	0.00123	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PPARG—colon cancer	3.3e-06	0.00116	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—PIK3CA—colon cancer	3.27e-06	0.00115	CbGpPWpGaD
Azathioprine—HPRT1—Metabolism—AKT1—colon cancer	3.05e-06	0.00108	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—EP300—colon cancer	2.98e-06	0.00105	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—EP300—colon cancer	2.9e-06	0.00102	CbGpPWpGaD
Azathioprine—GSTA1—Metabolism—AKT1—colon cancer	2.67e-06	0.000941	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—PIK3CA—colon cancer	2.63e-06	0.000928	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PTGS2—colon cancer	2.59e-06	0.000914	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—PIK3CA—colon cancer	2.21e-06	0.000778	CbGpPWpGaD
Azathioprine—XDH—Metabolism—EP300—colon cancer	2.16e-06	0.00076	CbGpPWpGaD
Azathioprine—TPMT—Metabolism—AKT1—colon cancer	2.15e-06	0.000758	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—PIK3CA—colon cancer	2.15e-06	0.000757	CbGpPWpGaD
Azathioprine—GSTA2—Metabolism—AKT1—colon cancer	1.8e-06	0.000636	CbGpPWpGaD
Azathioprine—GSTM1—Metabolism—AKT1—colon cancer	1.75e-06	0.000618	CbGpPWpGaD
Azathioprine—XDH—Metabolism—PIK3CA—colon cancer	1.6e-06	0.000563	CbGpPWpGaD
Azathioprine—XDH—Metabolism—AKT1—colon cancer	1.3e-06	0.00046	CbGpPWpGaD
